Clinical Trial: RT-310 Dose Escalation BPH Study
Study Status: Completed
Recruit Status: RECRUITING
Condition: BPH (Benign Prostatic Hyperplasia)
Study Type: INTERVENTIONAL
Official Title: Safety and Feasibility Dose Escalation Study for Evaluation of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Brief Summary:
RT-310, a novel implant, is intended to minimally invasive treat locally the prostate gland for the management of prostate disease, while minimizing side-effects.The objectives of the study are to assess whether RT-310 is safe and feasible for the participant population.
Read more